Toth Financial Advisory Corp Takes $713,000 Position in DaVita Inc. $DVA

Posted by on Aug 29th, 2026

Toth Financial Advisory Corp bought a new position in DaVita Inc. (NYSE:DVA – Free Report) in the 2nd quarter, HoldingsChannel reports. The fund bought 3,205 shares of the company’s stock, valued at approximately $713,000.

Other large investors have also recently bought and sold shares of the company. Root Financial Partners LLC lifted its stake in DaVita by 128.0% in the 1st quarter. Root Financial Partners LLC now owns 187 shares of the company’s stock worth $29,000 after acquiring an additional 105 shares in the last quarter. Caitlin John LLC purchased a new position in DaVita during the 4th quarter valued at about $34,000. Sankala Group LLC acquired a new position in shares of DaVita in the 4th quarter valued at about $39,000. Canada Pension Plan Investment Board acquired a new position in shares of DaVita in the 2nd quarter valued at about $43,000. Finally, Kestra Advisory Services LLC purchased a new stake in shares of DaVita in the fourth quarter worth approximately $45,000. 90.12% of the stock is owned by institutional investors and hedge funds.

DaVita Price Performance

Shares of DaVita stock opened at $180.72 on Friday. The firm has a market cap of $11.53 billion, a price-to-earnings ratio of 14.79, a P/E/G ratio of 0.46 and a beta of 0.88. The stock has a 50-day simple moving average of $211.96 and a 200-day simple moving average of $183.05. DaVita Inc. has a 52-week low of $101.00 and a 52-week high of $247.49.

DaVita (NYSE:DVA – Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $4.02 EPS for the quarter, topping analysts’ consensus estimates of $3.88 by $0.14. The firm had revenue of $3.55 billion for the quarter, compared to the consensus estimate of $3.50 billion. DaVita had a negative return on equity of 217.63% and a net margin of 6.05%.The firm’s revenue was up 5.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.95 earnings per share. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. As a group, equities research analysts predict that DaVita Inc. will post 14.57 earnings per share for the current year.

Analyst Ratings Changes

A number of research analysts recently commented on the stock. Oppenheimer set a $220.00 price objective on shares of DaVita in a research report on Friday, August 7th. TD Cowen raised shares of DaVita from a “hold” rating to a “buy” rating and lifted their target price for the company from $201.00 to $220.00 in a research note on Friday, August 7th. Zacks Research cut shares of DaVita from a “strong-buy” rating to a “hold” rating in a report on Monday, July 6th. Truist Financial dropped their price target on shares of DaVita from $250.00 to $215.00 and set a “hold” rating on the stock in a research note on Friday, August 7th. Finally, UBS Group increased their price objective on DaVita from $235.00 to $270.00 and gave the stock a “buy” rating in a report on Friday, July 10th. Four research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $221.75.

View Our Latest Stock Report on DVA

Insider Activity at DaVita

In other news, insider Kathleen Alyce Waters sold 15,405 shares of the firm’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $208.40, for a total transaction of $3,210,402.00. Following the transaction, the insider owned 109,194 shares in the company, valued at approximately $22,756,029.60. This trade represents a 12.36% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.90% of the stock is currently owned by company insiders.

DaVita Profile

(Free Report)

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.

Read More

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA – Free Report).

Institutional Ownership by Quarter for DaVita (NYSE:DVA)

Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.